1. Home
  2. LRMR vs XPER Comparison

LRMR vs XPER Comparison

Compare LRMR & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • XPER
  • Stock Information
  • Founded
  • LRMR N/A
  • XPER 1990
  • Country
  • LRMR United States
  • XPER United States
  • Employees
  • LRMR N/A
  • XPER N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • XPER Semiconductors
  • Sector
  • LRMR Health Care
  • XPER Technology
  • Exchange
  • LRMR Nasdaq
  • XPER Nasdaq
  • Market Cap
  • LRMR 309.8M
  • XPER 370.5M
  • IPO Year
  • LRMR N/A
  • XPER 2003
  • Fundamental
  • Price
  • LRMR $3.89
  • XPER $6.08
  • Analyst Decision
  • LRMR Strong Buy
  • XPER Strong Buy
  • Analyst Count
  • LRMR 8
  • XPER 2
  • Target Price
  • LRMR $17.88
  • XPER $13.50
  • AVG Volume (30 Days)
  • LRMR 1.4M
  • XPER 514.0K
  • Earning Date
  • LRMR 10-29-2025
  • XPER 11-05-2025
  • Dividend Yield
  • LRMR N/A
  • XPER N/A
  • EPS Growth
  • LRMR N/A
  • XPER N/A
  • EPS
  • LRMR N/A
  • XPER N/A
  • Revenue
  • LRMR N/A
  • XPER $475,219,000.00
  • Revenue This Year
  • LRMR N/A
  • XPER N/A
  • Revenue Next Year
  • LRMR N/A
  • XPER $3.06
  • P/E Ratio
  • LRMR N/A
  • XPER N/A
  • Revenue Growth
  • LRMR N/A
  • XPER N/A
  • 52 Week Low
  • LRMR $1.61
  • XPER $5.69
  • 52 Week High
  • LRMR $9.50
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 54.32
  • XPER 44.83
  • Support Level
  • LRMR $3.59
  • XPER $5.82
  • Resistance Level
  • LRMR $4.08
  • XPER $6.10
  • Average True Range (ATR)
  • LRMR 0.28
  • XPER 0.18
  • MACD
  • LRMR -0.01
  • XPER 0.06
  • Stochastic Oscillator
  • LRMR 58.33
  • XPER 38.64

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: